![Controlled Correspondence article graphic[1].jpg](https://cdn.sanity.io/images/0vv8moc6/pharmexec/53857f180a628d842a88ca8e05e255aa63d03c1a-1672x801.jpg?w=350&fit=crop&auto=format)
As part of FDA’s ongoing effort to modernize interactions with industry, FDA launched a portal to help with submissions of controlled correspondence via email instead of manual data entry.
![Controlled Correspondence article graphic[1].jpg](https://cdn.sanity.io/images/0vv8moc6/pharmexec/53857f180a628d842a88ca8e05e255aa63d03c1a-1672x801.jpg?w=350&fit=crop&auto=format)
As part of FDA’s ongoing effort to modernize interactions with industry, FDA launched a portal to help with submissions of controlled correspondence via email instead of manual data entry.
![Controlled Correspondence article graphic[1].jpg](https://cdn.sanity.io/images/0vv8moc6/pharmexec/53857f180a628d842a88ca8e05e255aa63d03c1a-1672x801.jpg?w=300&fit=crop&auto=format)
Published: March 11th 2019 | Updated: